Stock Events

Stock Events

Proteonomix 

$0
3
+$0+0% Monday 20:00

Statistics

Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
66,200
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

30JunExpected
Q3 2010
Q4 2010
Q1 2011
Q2 2011
Q3 2011
Q4 2011
Q1 2012
-0.28
-0.13
0.03
0.18
Expected EPS
0
Actual EPS
0.1817

People Also Follow

This list is based on the watchlists of people on Stock Events who follow PROT. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Biomarin Pharmaceutical
BMRN
Mkt Cap10.29B
BioMarin Pharmaceutical Inc. focuses on enzyme replacement therapies which is similar to Proteonomix's focus on biotechnological treatments.
Vertex Pharmaceuticals
VRTX
Mkt Cap109.11B
Vertex Pharmaceuticals works on cell therapies and genetic research, areas that overlap with Proteonomix’s interests in stem cell biotechnology.
Sangamo Therapeutics
SGMO
Mkt Cap180.42M
Sangamo Therapeutics, Inc. specializes in genomic medicine, competing in the advanced biotechnological space similar to Proteonomix.
CRISPR Therapeutics
CRSP
Mkt Cap5.82B
CRISPR Therapeutics AG engages in gene editing, a cutting-edge technology that is in direct competition with Proteonomix’s biotechnological innovations.
Novartis
NVS
Mkt Cap237.61B
Novartis AG conducts extensive research in bio-pharmaceuticals, including areas like regenerative medicine which competes with Proteonomix’s offerings.
Pfizer
PFE
Mkt Cap140.15B
Pfizer Inc. has a broad portfolio in biopharmaceuticals, including developments in biotechnology that could rival Proteonomix’s products.
Gilead Sciences
GILD
Mkt Cap148.78B
Gilead Sciences, Inc. is known for its work in the biopharmaceutical field, competing in the same sector as Proteonomix.
AMGEN
AMGN
Mkt Cap160.66B
Amgen Inc. explores biotechnological treatments for various diseases, aligning closely with Proteonomix’s market and research focus.
Alnylam Pharmaceuticals
ALNY
Mkt Cap60.25B
Alnylam Pharmaceuticals, Inc. works on RNAi therapeutics, a novel biotechnological approach that could compete with Proteonomix’s strategies.

About

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company's products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.
Show more...
CEO
Mr. Michael Cohen
Country
US
ISIN
US74371C2089

Listings

OTC Link
US
PROT

0 Comments

Share your thoughts

FAQ

What is Proteonomix stock price today?▼
The current price of PROT is $0 USD — it has increased by +0% in the past 24 hours. Watch Proteonomix stock price performance more closely on the chart.
What is Proteonomix stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Proteonomix stocks are traded under the ticker PROT.
What were Proteonomix earnings last quarter?▼
PROT earnings for the last quarter are 0.18 USD per share, whereas the estimation was 0 USD resulting in a +∞% surprise. The estimated earnings for the next quarter are N/A USD per share.
In which sector is Proteonomix located?▼
Proteonomix operates in the Health Care sector.
When did Proteonomix complete a stock split?▼
Proteonomix has not had any recent stock splits.
Where is Proteonomix headquartered?▼
Proteonomix is headquartered in Hawthorne, US.